Quick Takeaways
- Copeland Capital Management, LLC filed SCHEDULE 13G for LEMAITRE VASCULAR INC Common Stock (LMAT).
- Disclosed ownership: 5.2%.
- Date of event: 31 Dec 2024.
Copeland Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G Report for LEMAITRE VASCULAR INC Common Stock (LMAT)
- Filing Manager
- Copeland Capital Management, LLC
- Reporting Manager
- Copeland Capital Management
- Security
- LEMAITRE VASCULAR INC Common Stock
- Symbol
- LMAT
- Shares outstanding
- 18,982,342 shares
- Disclosed Ownership
- 988,980 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Jan 2025, 13:34:33 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Copeland Capital Management, LLC disclosed 5.2% ownership in LEMAITRE VASCULAR INC Common Stock (LMAT) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Jan 2025, 13:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Copeland Capital Management | 5.2% | 988,980 | 803,212 | 185,768 | /s/ Sofia A. Rosala | General Counsel and CCO |